BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR
78.40
+1.35 (+1.75%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Previous Close77.05
Open77.40
Bid0.00 x 28400
Ask0.00 x 2100
Day's Range76.87 - 79.11
52 Week Range75.50 - 118.04
Volume7,033,882
Avg. Volume3,657,279
Market Cap73.222B
Beta0.90
PE Ratio (TTM)9.49
EPS (TTM)8.26
Earnings DateSep 5, 2018
Forward Dividend & Yield2.76 (2.93%)
Ex-Dividend Date2018-05-28
1y Target Est120.99
  • The Wall Street Journal2 days ago

    The Score: The Business Week in 7 Stocks

    Reports that the United States and China were working to resolve their monthslong trade dispute sent major indexes upwards on Thursday, with the Dow Jones Industrial Average notching its biggest one-day gain since April with a 396-point jump. The S&P 500 also inched 0.6% higher to 2,850.13 this week, though the Nasdaq Composite slipped 0.3% to 7,816.33 as tech stocks came under pressure. Among individual stocks: Nielsen Holdings Plc leapt 12% on Monday as activist investor Elliott Management Corp. had taken a sizeable stake and planned to urge the company to sell itself.

  • Bloomberg2 days ago

    The Other Monsanto Chemical That Bayer Investors Should Watch

    Some Bayer AG investors were surprised to learn about the thousands of farmers lining up before U.S. courts to argue that Roundup -- the blockbuster weedkiller the German company recently acquired when it bought Monsanto Co. -- had given them cancer. There are also lawsuits aplenty for dicamba, its next best-selling herbicide, which U.S. farmers are spraying on about 60 million acres of soybean and cotton crops this summer to combat weeds that have become resistant to Roundup.

  • Reuters2 days ago

    Bayer says dicamba report not new

    FRANKFURT (Reuters) - Bayer (BAYGn.DE) said on Friday that a German media report this week that U.S. farmers were suing its Monsanto unit over crop damage caused by weedkiller dicamba does not represent ...

  • Reuters2 days ago

    Bayer says dicamba report not new

    Bayer said on Friday that a German media report this week that U.S. farmers were suing its Monsanto unit over crop damage caused by weedkiller dicamba does not represent a new development. Bayer shares fell on Thursday, with traders citing a report by German weekly WirtschaftsWoche saying farmers in Arkansas and South Dakota had filed new class action lawsuits against Monsanto and against BASF with a St. Louis court. The cases, which were directed at number of other companies, "have been known about for quite some time, and media from the United States and Germany have already reported on this matter", Bayer said.

  • Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication
    Zacks2 days ago

    Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication

    Bayer's (BAYRY) Monsanto subsidiary faces $289 million fine in Roundup lawsuit. Merck/Eisai's drug Lenvima gets FDA approval to treat the most common form of liver cancer.

  • Reuters2 days ago

    Bayer says can begin integration of Monsanto

    Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • This New Biotech Industry Could Pose a Huge Risk to Fertilizer Stocks
    Motley Fool2 days ago

    This New Biotech Industry Could Pose a Huge Risk to Fertilizer Stocks

    Next-generation biotech products could threaten the existence of agricultural nutrient producers, but few seem to be taking notice.

  • Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer
    Reuters3 days ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    America's two biggest independent seed sellers, Beck's Hybrids and Stine Seed, told Reuters they are pushing U.S. environmental regulators to bar farmers from spraying dicamba weed killer during upcoming summers in a potential blow to Bayer AG's Monsanto Co. Limiting spraying of the chemical to the spring season, before crops are planted, would prevent farmers from using the herbicide on dicamba-resistant soybeans that Monsanto engineered. The seeds are sold by companies including Beck's and Stine.

  • Reuters3 days ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    America's two biggest independent seed sellers, Beck's Hybrids and Stine Seed, told Reuters they are pushing U.S. environmental regulators to bar farmers from spraying dicamba weed killer during upcoming summers in a potential blow to Bayer AG's Monsanto Co. Limiting spraying of the chemical to the spring season, before crops are planted, would prevent farmers from using the herbicide on dicamba-resistant soybeans that Monsanto engineered. The seeds are sold by companies including Beck's and Stine.

  • Associated Press3 days ago

    Germany's Bayer says it can start integrating Monsanto

    BERLIN (AP) — German pharmaceutical company Bayer AG says it can now start integrating U.S. seed and weed-killer maker Monsanto Co. after completing the required sale of some of its crop science business.

  • Financial Times3 days ago

    [$$] Bayer falls again after latest legal setback over Monsanto weedkiller

    The decision late on Wednesday by the California Supreme Court marks the latest blow to Roundup-maker Monsanto, which was acquired by Bayer in June for $62.5bn. Monsanto had sued a division of California’s Environmental Protection Agency for its decision to add glyphosate to its list of hazardous chemicals.

  • Bayer Vows Stronger Roundup Defense as It Absorbs Monsanto
    Bloomberg3 days ago

    Bayer Vows Stronger Roundup Defense as It Absorbs Monsanto

    Bayer AG vowed to step up its defense against a wave of U.S. lawsuits over the herbicide Roundup as it began the formal integration of Monsanto Co., acquired for $66 billion in June. Because U.S. authorities insisted that the businesses operate separately until that sale was complete, Bayer said it previously had been barred from steering Monsanto’s legal strategy. Bayer is facing $289 million in damages after Monsanto lost the first court case stemming from claims that the weed killer causes cancer.

  • Bayer says can begin integration of Monsanto
    Reuters3 days ago

    Bayer says can begin integration of Monsanto

    Bayer (BAYGn.DE) can begin folding Monsanto into its organization as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF (BASFn.DE) of certain Crop Science businesses with a total sales volume of around 2.2 billion euros," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • Bayer Shares Slide as Legal Troubles Mount Over Herbicides
    Bloomberg3 days ago

    Bayer Shares Slide as Legal Troubles Mount Over Herbicides

    Bayer AG shares continued their slide after the company failed to block California’s move to list the herbicide Roundup as a known carcinogen. The California Supreme Court declined on Wednesday to hear arguments by Monsanto, recently acquired by Bayer, as to why Roundup, the world’s most widely used weed killer, doesn’t belong on the state’s list of chemicals known to cause cancer. The California Court of Appeal, Fifth District, had rejected the U.S. company’s arguments in April.

  • Financial Times3 days ago

    [$$] Real productivity is an efficiency measure

    This is supposed to be a problem because “productivity, output per hour worked, is the way nations become richer, living standards rise and governments have the resources to improve public services or cut taxes”. The problem lies with Mr Giles’s definition when he says that “labour productivity is normally measured as the value of goods and services produced for each hour worked”. Here he confuses real productivity as an efficiency measure, where input (labour hours) is compared to physical output (number of cars, etc), with a value measure where physical efficiency is combined with the ability of the producer to set prices.

  • Financial Times3 days ago

    [$$] US legal woes drive Bayer shares to 5-year low

    The California Supreme Court on Wednesday declined to hear Monsanto’s appeal to have the main chemical in the product — which will become part of the Bayer portfolio as a result of its $62.5bn acquisition of Monsanto — removed from an official list of carcinogenic substances. Bayer shares fell more than 6 per cent to €76 in afternoon trading on Thursday, amid heightened investor concern over the group’s exposure to glyphosate legal risks.

  • The Wall Street Journal4 days ago

    [$$] Round Up the Usual Lawyers

    On Friday a California jury ordered Monsanto to pay $289.2 million in damages for failing to give sufficient warning about the “substantial dangers” of its signature weed killer known as Roundup. Shares of Bayer, which recently acquired Monsanto, have plummeted this week in anticipation of a legal onslaught from plaintiff lawyers. The San Francisco Superior Court case involved Dewayne “Lee” Johnson, who was diagnosed with non-Hodgkin lymphoma in 2014.

  • 3 Top Stocks in Digital Agriculture
    Motley Fool4 days ago

    3 Top Stocks in Digital Agriculture

    Companies across the agricultural value chain are investing in digital tools to help farmers. Here are three to put on your radar.

  • Novo Nordisk’s Biopharmaceuticals Segment: An Update
    Market Realist4 days ago

    Novo Nordisk’s Biopharmaceuticals Segment: An Update

    Novo Nordisk’s (NVO) biopharmaceuticals segment generated revenues of 4.4 billion Danish kroner in the second quarter of 2018, a ~4% YoY (year-over-year) decline in local currencies.

  • Reuters4 days ago

    Analysis: Monsanto Roundup appeal has uphill climb on 'junk science' grounds - legal experts

    Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • The Wall Street Journal4 days ago

    [$$] David Einhorn’s Bayer Pick Hit in Monsanto Ruling

    A top stock pick of hedge-fund manager David Einhorn was stung this week by the loss of a crucial case in California, the latest potential setback for the billionaire investor. Shares in Bayer AG fell sharply on Monday after Monsanto Co.—which the German chemical company recently acquired—was ordered to pay $289.2 million in a landmark lawsuit over whether exposure to two of its weed killers caused cancer. The ruling by a California state jury on Friday found that Monsanto’s Roundup and Ranger Pro products presented a “substantial danger” to consumers, and that the St. Louis-based company knew—or should have known—the potential risks they posed.

  • Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
    Reuters5 days ago

    Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts

    Bayer AG (BAYGn.DE) unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit
    Zacks5 days ago

    Bayer Plunges as Monsanto Fined $289M in Roundup Lawsuit

    Shares of Bayer (BAYRY) crash as its newly acquired company Monsanto was fined $289 million over allegations that its weedkiller caused cancer.

  • Financial Times5 days ago

    [$$] Daily briefing: Lira relief, Musk move, London ‘terror’ probe

    In early London dealings the lira rose 6 per cent, but is down a quarter this month. Turkey is facing severe issues on several fronts, including US relations. Washington has been pressuring Ankara to release detained American pastor Andrew Brunson, and analysts say a resolution is a critical factor in stabilising the lira.

  • In Monsanto, Bayer Investors Inherit Hard-to-Predict Risk
    Bloomberg5 days ago

    In Monsanto, Bayer Investors Inherit Hard-to-Predict Risk

    Bayer AG investors can take heart that a $289 million verdict against its newly acquired Monsanto unit will be challenged on appeal, but they’re not wrong to dread thousands more lawsuits alleging that the company’s popular Roundup herbicide causes cancer. Some financial analysts predicted the Aug. 10 jury award in San Francisco will be knocked down or wiped out entirely, while legal experts warned of more uncertainty ahead. More than 5,000 U.S. residents have joined similar lawsuits against Monsanto -- and the lawyer who won the trial said an equal number are poised to file new claims.